Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-11

Clinical Trial Update: From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers [NA]

View source ↗

Summary

This clinical trial update discusses deregulation of the cholesterol-epoxide pathway in breast cancer and explores potential new therapeutic perspectives.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Breast Cancer | NA | Status: UNKNOWN